Table 3.
Outcome measure | Estimation | |||
---|---|---|---|---|
Definition | Rate constants | Distribution volumes | Occupancy calculation | |
BP ND (specific to nondisplaceable binding potential) | B max/K D ● f ND | k 3/k 4 a | V T/V ND − 1 b | BP ND baseline − BP ND drug / BP ND baseline |
V T | V S+V ND | K 1/k 2 (1+k 3/k 4) | ‐ | V T drug − V T baseline = OCC ● (V T − V ND) |
λk3 c | λ = K 1/k 2 | K1/k2 ● k 3 | ‐ | λk3 baseline − λk3 drug / λk3 baseline |
B max, max number of available receptors(targets); K D, dissociation rate constant; PET, positron emission tomography; V ND, nondisplaceable distribution volume (usually measured in a reference region); V S, distribution volume of the radioligand bound to the target.
k 3/k 4 can be estimated with 2‐tissue compartment model (TCM) or with simplified reference tissue model (SRTM).
V T and V ND can be estimated with 1‐TCM or 2‐TCM or with linear or multilinear graphical analysis (Logan plot or multilinear analysis) or with reference Logan or MRTM in case a reference region in the brain is present.
λk3 is the outcome measure conventionally used in case of an irreversible radioligand.